Welcome to THE ZOU LAB
Research on Inorganic Chemical Biology and Medicinal Inorganic Chemistry
The research in Taotao's lab lies at the interface of chemistry and biology, particularly, medicinal chemistry and chemical biology of metal complexes, including anti-cancer compounds with in vitro and in vivo activities, immunogenic cell death inducers, drug target identification, luminescent DNA probes, and drug self-assembly and delivery.
News in the Lab
Moyi's paper entitled "Photoactivation of Boronic Acid-Prodrugs via a Phenyl Radical Mechanism: Iridium(III) Anticancer Complex as an Example" has been accepted by JACS. Well done!
April 17, 2023
Boronic acid (or ester) is a well-known temporary masking group for developing anticancer prodrugs responsive to tumoral ROS, but their clinic application is largely hampered by the low activation efficiency. Herein, we report a robust photoactivation approach that can spatiotemporally convert boronic acid-caged iridium(III) complex IrBA into bioactive IrNH2 under hypoxic tumor microenvironments. Mechanistic studies show that the phenyl boronic acid moiety in IrBA is in equilibrium with phenyl boronate anion that can be photo-oxidized to generate phenyl radical, a highly reactive species that is capable of rapidly capturing O2 at extremely low concentrations (down to 0.02%). As a result, while IrBA could hardly be activated by intrinsic ROS in cancer cells, upon light irradiation, the prodrug is efficiently converted into IrNH2 even in limited O2 supply, along with direct damage to mitochondrial DNA and potent antitumor activities in hypoxic 2D monolayer cells, 3D tumor spheroids, and mouse-bearing tumor xenografts. Of note, the photoactivation approach could be extended to intermolecular photocatalytic activation by external photosensitizers with red absorption and to activate prodrugs of clinic compound, thus offering a general approach for activation of anti-cancer organoboron prodrugs.
A review paper entitled "Modulating the Chemical Reactivity of Gold Complexes in Living Systems: From Concept to Biomedical Applications" was accepted in Acc. Chem. Res. Congrates to Jiang jia and Xiaolin.
Apr-10-2023
This paper summarizes our recent series works on stimuli-activatable gold prodrugs. It is hoped that this account will spur the creation of better approaches to advance gold complexes closer to clinical application.
Yunli's paper on conditionally activatable anticancer gold complexes was accepted for publication in Angew. Chem. Congrats!
Sep 16, 2022
Our paper entitled "Organogold(III) Complexes Display Conditional Photoactivities: Evolving From Photodynamic into Photoactivated Chemotherapy in Response to O2 Consumption for Robust Cancer Therapy" has been accepted for publication in Angewandte Chemie! Please check details in https://onlinelibrary.wiley.com/doi/10.1002/anie.202212689
A paper on molecular mechanism of ICD inducers was accepted in JACS! Congratulations to Xiaolin & Wang Yuan!
May 20, 2022
Our paper titled "Target Profiling of an Iridium(III)-based Immunogenic Cell Death Inducer Unveils the Engagement of Unfolded Protein Response Regulator BiP" was accepted for publication in JACS.
Hejiang, Yuting, Yunli, Wang Yuan successfully passed their thesis oral defense, congratulations!
May 18, 2022
Hejiang (PhD), Yuting (master), Yunli (master), Wang Yuan (master) successfully passed their thesis oral defense, congratulations!
New paper accepted in ACIE! Congratulations to Jia Jiang, Bei Cao and Yuting Chen!
Feb 15, 2022
Our paper entitled "Alkylgold(III) Complexes Undergo Unprecedented Photo-Induced β-Hydride Elimination and Reduction for Targeted Cancer Therapy" has been accepted for publication in Angew Chem! Check details at https://onlinelibrary.wiley.com/doi/10.1002/anie.202201103
News sharing from the Unviersity and the School:
中山大学药学院邹滔滔教授课题组在抗癌金配合物研究中取得重要进展 - 中山大学新闻网 (sysu.edu.cn)
邹滔滔教授课题组在抗癌金配合物研究中取得重要进展 | 中山大学药学院 (sysu.edu.cn)
Xiaolin got his paper published in Coord. Chem. Rev. Congratulations!
November 24, 2021
The paper summarized approaches for deciphering the mechanism-of-action of metal complexes and
highlighted selected examples with in-depth mechanistic insights. Check details at https://www.sciencedirect.com/science/article/pii/S0010854521005853
Zhi Zhong (钟智) joins the Lab
September 1, 2021
Zhi Zhong (BSc SMU) joins the lab as a master student, welcome!
Congratulations to Taotao for awarding NSFC for Excellent Young Scholars
祝贺邹老师获得国家优秀青年基金项目
Aug 18, 2021
A 2M NSFC fund is now awarded to Taotao!
Congratulations to Xiaolin for awarding the Youth Fund of NSFC
祝贺啸林博士获得国自然青年基金项目
Aug 18, 2021
A 240,000 RMB NSFC fund is now awarded to Xiaolin! Excellent!
Yan Long (龙艳) obtained her master degree as an outstanding graduate of SYSU!
Jun 30, 2021
All the best!
中山大学2021年优秀博士、硕士学位论文评选结果公示 | 中山大学研究生院 (sysu.edu.cn)
Can Yang (杨灿) Joins the Lab!
May 26, 2021
Can Yang (BSc & Msc TJU) joins the lab, welcome!
Yan Yang (杨燕) Joins the Lab
April 6, 2021
Yan Yang (BSc SMU) joins the lab, welcome!
Highlight by ChemBioChem
Jan 28, 2021
The development of metal‐based anticancer drugs has been hampered, among other reasons, by their lack of selectivity for cancer cells. In a recent article, Zou and co‐workers presented the successful intracellular activation of organogold(I) complexes for potential cancer treatment through Pd(II)‐mediated transmetallation, overcoming some off‐target activity of novel gold‐based drugs. This unique strategy builds the perfect bridge between metallodrug usage and bioorthogonal intracellular catalysis for more advanced and selective therapies. Such an approach will hopefully pave the way for forthcoming studies in medicinal inorganic chemistry. (https://doi.org/10.1002/cbic.202100015)
Highlight from WileyChem
Nov 13, 2020
News sharing from the department
Nov 12, 2020
Long Yan got her paper published in Angew Chem! Congrats!
Nov 5, 2020
A paper entitled "Bioorthogonal Activation of Dual Catalytic and Anti-Cancer Activities of Organogold(I) Complexes in Living Systems" has been accepted for publication in Angewandte Chemie! Check details in https://www.onlinelibrary.wiley.com/doi/10.1002/anie.202013366
Hejiang wins the national scholarship! Congratulations!
Oct 22, 2020
Check details in http://sps.sysu.edu.cn/article/11518
Taotao is awarded with 2020 AsBIC Graeme Hanson Early Career Award! Congratulations!
Aug 22, 2020
Dr. Taotao Zou is awarded with 2020 Graeme Hanson Early Career Award (ECA) by Asian Biological Inorganic Chemistry (AsBIC) committee. The first time ECA enters mainland China!
Yuhan (MSc 2020) joins the lab!
Aug 3, 2020
Yuhan Lao (BSc CPU) joins the lab, welcome!
Xiaolin (postdoc) joins the lab
July 20, 2020
Xiaolin Xiong (BSc WHU, PhD WHU) joins the lab as our first postdoc. Welcome!
Cover Picture
May 26, 2020
Highlight in Angew Chem: A photoactivatable prodrug approach overcomes the deactivation of drugs based on gold complexes caused by off‐target binding to serum albumin. In their Research Article (DOI: 10.1002/anie.202000528), T. Zou et al. show that gold(III) hydride complexes are inert towards serum albumin in the dark. Once they enter tumor tissues, their thiol reactivity can be photochemically activated, thereby leading to potent inhibition of tumor thiol enzymes through the formation of Au−S bonds.
Paper accepted in ACIE as a Hot Paper, Congrats Hejiang!
March 24, 2020
Light-controlled thiol-reactivity: Stable cyclometalated gold(III)-hydride complexes can photo-dissociate hydride ligand and form coordinative [Au-S] adducts, leading to potent suppression of thioredoxin reductase, up to >400-fold increase of cytotoxicity (vs dark) towards different cancer cells with little influence by serum albumin, and strong inhibition of angiogenesis in zebrafish models by one- or two-photon excitation.
Jia Jiang Joins the Lab
March 4, 2020
Jia Jiang (BSc SWU, MSc CQU) joins the lab in this special season. Welcome!